Immunocontraception of male and female giraffes using the GnRH vaccine Improvac®
Autor: | Franz Schwarzenberger, Christina Geiger, Eva Martinez Nevado, Nicole Schauerte, Folko Balfanz, Florian Sicks, Anna Hein, Christine Kaandorp-Huber, Gwendoline Anfray, Sandra Marcordes, Tobias Knauf-Witzens, Sophia-Maria Jeserschek, Pia Krawinkel, Betina Venshøj |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
media_common.quotation_subject Physiology Giraffes Biology Gonadotropin-Releasing Hormone medicine Animals media_common.cataloged_instance Endocrine system Contraception Immunologic media_common Immunocontraception Vaccines Testicular atrophy General Medicine medicine.disease Vaccination medicine.anatomical_structure Animals Zoo Female Animal Science and Zoology Reproduction Corpus luteum Giraffa camelopardalis Hormone |
Zdroj: | Zoo Biology. 41:50-64 |
ISSN: | 1098-2361 0733-3188 |
Popis: | The aim of this study was to develop protocols for contraception in both sexes of giraffes (Giraffa camelopardalis) by using the GnRH vaccine Improvac®. We evaluated the success of immunization by analyzing fecal reproductive hormone metabolites in female (n = 20) and male (n = 9) giraffes. Endocrine analysis provided the basis for the successful immunization protocol, as well as for assessing long-term effects. Reliable reduction of fecal steroid metabolites to baseline levels in female giraffes was achieved with three, and in males with four or five injections at 4-week intervals. Effective booster injections were administered at 2-month intervals in the first year of treatment and at three to 4-month intervals in the following years. In addition to endocrine analysis, we determined vaccination efficacy in bulls by assessing testicular atrophy. Long-term (>2 years) use in females was often accompanied by prolonged periods of persistent corpus luteum activity, although normal cycles were not observed. Problems might occur with reversibility, because in a few males and females, even after more than 2 years since treatment had been stopped, fecal hormone metabolites have not returned to pretreatment levels. The results are somewhat ambiguous, as reproduction can be suppressed by use of Improvac®, but the question of reversibility remains unsolved. |
Databáze: | OpenAIRE |
Externí odkaz: |